Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Atea Pharmaceuticals, Inc. | StockGist | StockGist

Companies
AVIR
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings AVIRSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Atea Pharmaceuticals, Inc.

Filed Feb 9, 2026

Accepted Feb 9, 2026, 12:00 AM ET

CIK 0001593899

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Atea Pharmaceuticals, Inc.

Person Type

PN

CUSIP: 04683R106

Amendment History

6 filings

SCHEDULE 13G
Original
Viewing
Feb 9, 20260001373604-26-000010
SCHEDULE 13G/A
Amendment 1
Feb 14, 20250000935836-25-000162
SCHEDULE 13G/A
Amendment 2
Apr 23, 20250002052113-25-001472
SCHEDULE 13G/A
Amendment 3
May 14, 20250000950170-25-071707
SCHEDULE 13G/A
Amendment 4
Aug 6, 20250000315066-25-001974
SCHEDULE 13G/A
Amendment 5
Latest
Dec 5, 20250000315066-25-002957

Recent Filings

Atea Pharmaceuticals, Inc.1 months ago

Atea Pharmaceuticals, Inc.1 months ago

Atea Pharmaceuticals, Inc.2 months ago

Atea Pharmaceuticals, Inc.4 months ago

Atea Pharmaceuticals, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice